本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.05
-1.0300-8.53%
成交量:26.34萬
成交額:296.77萬
市值:3.85億
市盈率:-9.98
高:12.37
開:12.11
低:10.96
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,488.27萬
流通股本:1,845.34萬
量比:2.85
換手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):-1.1074
每股收益(LYR):-0.9800
淨資產收益率:-33.21%
總資產收益率:-22.67%
市淨率:2.18
市盈率(LYR):-11.28

資料載入中...

2020/10/27

重要事件披露

8-K - Current report
2020/10/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/06

重要事件披露

8-K - Current report
2020/10/01

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/01

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/01

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/23

重要事件披露

8-K - Current report
2020/09/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/19

重要事件披露

8-K/A [Amend] - Current report
2020/08/18

重要事件披露

8-K - Current report
2020/08/14

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/06/05

重要事件披露

8-K - Current report
2020/04/15

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/03

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]